ATE194169T1 - Beta-type ähnlicher transformierender wachstumfaktor - Google Patents
Beta-type ähnlicher transformierender wachstumfaktorInfo
- Publication number
- ATE194169T1 ATE194169T1 AT92900433T AT92900433T ATE194169T1 AT E194169 T1 ATE194169 T1 AT E194169T1 AT 92900433 T AT92900433 T AT 92900433T AT 92900433 T AT92900433 T AT 92900433T AT E194169 T1 ATE194169 T1 AT E194169T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- tgf
- protein
- growth factor
- transforming growth
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61430690A | 1990-11-16 | 1990-11-16 | |
PCT/US1991/008606 WO1992008480A1 (en) | 1990-11-16 | 1991-11-18 | A β-TYPE TRANSFORMING GROWTH FACTOR |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE194169T1 true ATE194169T1 (de) | 2000-07-15 |
Family
ID=24460682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92900433T ATE194169T1 (de) | 1990-11-16 | 1991-11-18 | Beta-type ähnlicher transformierender wachstumfaktor |
Country Status (9)
Country | Link |
---|---|
US (1) | US5462925A (de) |
EP (1) | EP0557418B1 (de) |
JP (1) | JPH06505965A (de) |
AT (1) | ATE194169T1 (de) |
AU (1) | AU660635B2 (de) |
CA (1) | CA2096441A1 (de) |
DE (1) | DE69132275T2 (de) |
ES (1) | ES2149167T3 (de) |
WO (1) | WO1992008480A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN271295A0 (en) * | 1995-05-02 | 1995-05-25 | Gropep Pty Ltd | Method of treatment |
US6194376B1 (en) * | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
AU5405494A (en) * | 1992-10-30 | 1994-05-24 | Genentech Inc. | Method for preventing or treating liver disease |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
EP0710116B1 (de) * | 1993-05-13 | 2008-09-03 | Poniard Pharmaceuticals, Inc. | Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind |
US6197789B1 (en) * | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
EP1980246A1 (de) * | 1995-06-07 | 2008-10-15 | Poniard Pharmaceuticals, Inc. | Vorbeugung und Behandlung von kardiovaskulären Erkrankungen mit Tamoxifen-Analoga |
JP2000507939A (ja) | 1996-03-22 | 2000-06-27 | ザ ジェネラル ホスピタル コーポレーション | 中枢神経系の虚血または外傷後のポリペプチド成長因子の投与 |
US6846906B1 (en) | 1998-10-07 | 2005-01-25 | Stryker Corporation | Modified proteins of the TGF-β superfamily, including morphogenic proteins |
US7378432B2 (en) * | 2001-09-14 | 2008-05-27 | Tel Aviv University Future Technology Development L.P. | Glycogen synthase kinase-3 inhibitors |
EP2390262A1 (de) | 2003-05-16 | 2011-11-30 | Intermune, Inc. | Synthetische Chemokinrezeptorliganden und Verwendungsverfahren dafür |
WO2005032578A1 (en) | 2003-10-06 | 2005-04-14 | Monash University | Therapeutic method |
ES2527292T3 (es) | 2004-03-31 | 2015-01-22 | Genentech, Inc. | Anticuerpos anti-TGF-beta humanizados |
US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
WO2016140581A1 (en) * | 2015-03-05 | 2016-09-09 | Auckland Uniservices Limited | Ophthalmic compositions and methods of use therefor |
KR20190007026A (ko) | 2016-05-17 | 2019-01-21 | 제넨테크, 인크. | 면역요법에서의 진단 및 사용을 위한 기질 유전자 특질 |
CN111213059B (zh) | 2017-11-06 | 2024-01-09 | 豪夫迈·罗氏有限公司 | 用于癌症的诊断和治疗方法 |
WO2023080900A1 (en) | 2021-11-05 | 2023-05-11 | Genentech, Inc. | Methods and compositions for classifying and treating kidney cancer |
WO2024077166A1 (en) | 2022-10-05 | 2024-04-11 | Genentech, Inc. | Methods and compositions for classifying and treating lung cancer |
WO2024077095A1 (en) | 2022-10-05 | 2024-04-11 | Genentech, Inc. | Methods and compositions for classifying and treating bladder cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5115625A (ja) * | 1974-07-26 | 1976-02-07 | Hokko Chem Ind Co | Shushishodokuzai |
JPS5333738U (de) * | 1976-08-31 | 1978-03-24 | ||
JPS58121932A (ja) * | 1982-01-12 | 1983-07-20 | 太田 孝治 | チユ−ブ搾り装置 |
EP0105014B1 (de) * | 1982-09-24 | 1992-05-20 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Wiederherstellung von Gewebe bei Tieren |
JPS6034997A (ja) * | 1983-05-09 | 1985-02-22 | ジヨージ、ジヨセフ、トダロ | 生物学的活性ポリペプチド類 |
US4843063A (en) * | 1984-07-16 | 1989-06-27 | Collagen Corporation | Polypeptide cartilage-inducing factors found in bone |
US4886747A (en) * | 1985-03-22 | 1989-12-12 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
US4806523A (en) * | 1985-08-06 | 1989-02-21 | Collagen Corporation | Method of treating inflammation |
US4931548A (en) * | 1987-01-30 | 1990-06-05 | Techne Corporation | Heterodimer form of transforming growth factor-beta |
AU4056089A (en) * | 1988-07-20 | 1990-02-19 | Amgen, Inc. | Method of treating inflammatory disorders by reducing phagocyte activation |
-
1991
- 1991-11-18 AU AU90467/91A patent/AU660635B2/en not_active Ceased
- 1991-11-18 WO PCT/US1991/008606 patent/WO1992008480A1/en active IP Right Grant
- 1991-11-18 DE DE69132275T patent/DE69132275T2/de not_active Expired - Fee Related
- 1991-11-18 JP JP4501961A patent/JPH06505965A/ja active Pending
- 1991-11-18 AT AT92900433T patent/ATE194169T1/de not_active IP Right Cessation
- 1991-11-18 ES ES92900433T patent/ES2149167T3/es not_active Expired - Lifetime
- 1991-11-18 EP EP92900433A patent/EP0557418B1/de not_active Expired - Lifetime
- 1991-11-18 CA CA002096441A patent/CA2096441A1/en not_active Abandoned
-
1992
- 1992-11-20 US US07/979,441 patent/US5462925A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1992008480A1 (en) | 1992-05-29 |
EP0557418B1 (de) | 2000-06-28 |
US5462925A (en) | 1995-10-31 |
JPH06505965A (ja) | 1994-07-07 |
DE69132275D1 (de) | 2000-08-03 |
AU9046791A (en) | 1992-06-11 |
DE69132275T2 (de) | 2001-01-25 |
EP0557418A4 (en) | 1994-09-14 |
ES2149167T3 (es) | 2000-11-01 |
AU660635B2 (en) | 1995-07-06 |
EP0557418A1 (de) | 1993-09-01 |
CA2096441A1 (en) | 1992-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE194169T1 (de) | Beta-type ähnlicher transformierender wachstumfaktor | |
DE69129803D1 (de) | Wasserlösliche peptidanaloguen mit bindungstellen | |
NZ330897A (en) | Human trk receptors and neurotropic factor inhibitors | |
ES2147558T3 (es) | Nuevos polipeptidos para promover la fijacion celular. | |
PH20343A (en) | Cysteline-depleted muteins of biologically active proteins | |
ATE118015T1 (de) | Biologisch aktive polypeptide, die auf transformierten wachstumsfaktor-beta-sequenzen basieren. | |
ATE120374T1 (de) | Markierte polypeptidderivate. | |
ATE80166T1 (de) | Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form. | |
DE69129865T2 (de) | Osteogene peptide | |
PT731811E (pt) | Chaperonina 10 | |
DE69528531D1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
CA2010256A1 (en) | Protein anti-cancer agent | |
ATE110390T1 (de) | Wachstumsfaktor-rezeptor. | |
WO1992006199A3 (fr) | Peptides inducteurs d'anticorps inhibant des retrovirus du type hiv et anticorps diriges contre ces peptides | |
DK0467839T3 (da) | In-vitro-behandling af fusionsproteiner | |
ES2159536T3 (es) | Proteina que inhibe el crecimiento celular. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |